Tepkinly
基本信息
-
商品名Tepkinly
-
产品编号EMEA/H/C/005985
-
通用名epcoritamab
-
活性成分epcoritamab
-
中文名称艾可瑞妥单抗
-
治疗领域Lymphoma, Large B-Cell, Diffuse
-
ATC代码L01FX27
-
上市许可持有人AbbVie Deutschland GmbH & Co. KG
-
批准时间2023-09-22
-
版本
-
孤儿药yes
-
仿制药no
-
生物类似药no
-
加速评审no
-
附加条件批准yes
-
特殊评审no
-
额外监管yes
-
适应症Tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy.